Skip to main content
See every side of every news story
Published loading...Updated

In Axing mRNA Contract, Trump Delivers Another Blow to US Biosecurity, Former Officials Say

  • The Trump administration discontinued funding totaling $766 million that was allocated for creating mRNA vaccines targeting potential pandemic influenza strains, a move that former health security officials say weakens US biological defense.
  • This cancellation followed cuts to research budgets and policy changes that gutted health agencies amid warnings of the bird flu H5N1 as a key pandemic threat.
  • MRNA vaccines offer a faster development process by bypassing complex biological methods, yet since March, testing for bird flu has been conducted on just a small number of farmworkers in the U.S.
  • HHS communications director Andrew Nixon explained that continuing to fund Moderna’s H5N1 mRNA vaccine was deemed neither scientifically appropriate nor ethically defensible, in light of concerns about potential adverse effects.
  • Experts warn these actions worsen pandemic preparedness, risking reliance on others during future outbreaks, with former top vaccine adviser Peter Marks resigning over assaults on scientific truth.
Insights by Ground AI

21 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 62% of the sources are Center
62% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

abc News broke the news in New York, United States on Friday, June 6, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal